1. Home
  2. EVO vs CAC Comparison

EVO vs CAC Comparison

Compare EVO & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.96

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Camden National Corporation

CAC

Camden National Corporation

HOLD

Current Price

$54.75

Market Cap

923.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
CAC
Founded
1993
1875
Country
Germany
United States
Employees
4553
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
923.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
EVO
CAC
Price
$1.96
$54.75
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$7.00
$47.00
AVG Volume (30 Days)
44.2K
100.5K
Earning Date
04-08-2026
04-28-2026
Dividend Yield
N/A
3.51%
EPS Growth
N/A
6.08
EPS
N/A
1.29
Revenue
N/A
$41,739,000.00
Revenue This Year
$1.37
$19.15
Revenue Next Year
$10.05
$6.05
P/E Ratio
N/A
$41.55
Revenue Growth
N/A
16.96
52 Week Low
$1.94
$35.00
52 Week High
$4.42
$56.23

Technical Indicators

Market Signals
Indicator
EVO
CAC
Relative Strength Index (RSI) 25.35 58.28
Support Level N/A $52.15
Resistance Level $3.36 $56.10
Average True Range (ATR) 0.10 1.36
MACD -0.05 -0.15
Stochastic Oscillator 1.02 67.89

Price Performance

Historical Comparison
EVO
CAC

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

Share on Social Networks: